Breakthrough in Colon Cancer Treatment: Can an Old Anti-Inflammatory Reduce Recurrence Risk?
2025-01-31
Reuters
A promising new study reveals that patients with colon cancer may be able to reduce their risk of cancer recurrence with the daily use of celecoxib, a nonsteroidal anti-inflammatory pill. This breakthrough research suggests that celecoxib may improve survival odds for individuals with lingering cancer cells in their blood after surgery, offering new hope for those affected by this disease. By targeting inflammation, this old anti-inflammatory medication may help prevent colon cancer recurrence, making it a potential game-changer in the fight against this devastating illness. Key terms: colon cancer treatment, cancer recurrence, anti-inflammatory medication
